Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry

OBJECTIVES: We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic ech...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolodimeroff, Elena, Garg, Pankaj, Swift, Andrew J, Fent, Graham, Lewis, Nigel, Rogers, Dominic, Charalampopoulos, Athanasios, Al-Mohammad, Abdallah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161074/
https://www.ncbi.nlm.nih.gov/pubmed/35649572
http://dx.doi.org/10.1136/openhrt-2022-001974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161074/
https://www.ncbi.nlm.nih.gov/pubmed/35649572
http://dx.doi.org/10.1136/openhrt-2022-001974

Ejemplares similares